Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anette Heller"'
Autor:
Georg Gdynia, Tadeusz Robak, Jürgen Kopitz, Anette Heller, Svetlana Grekova, Katarina Duglova, Gloria Laukemper, Monika Heinzel-Gutenbrunner, Cornelius Gutenbrunner, Wilfried Roth, Anthony D. Ho, Peter Schirmacher, Michael Schmitt, Peter Dreger, Leopold Sellner
Publikováno v:
EBioMedicine, Vol 32, Iss , Pp 125-133 (2018)
A higher capacity to grow under hypoxic conditions can lead to a more aggressive behavior of tumor cells. Determining tumor activity under hypoxia may identify chronic lymphocytic leukemia (CLL) with aggressive clinical course and predict response to
Externí odkaz:
https://doaj.org/article/1bdfd4749002467fb4102dc814d0868a
Autor:
Matthias Neulinger-Muñoz, Dominik Schaack, Svetlana P. Grekova, Andrea S. Bauer, Thomas Giese, Gabriel A. Salg, Elisa Espinet, Barbara Leuchs, Anette Heller, Jürg P. F. Nüesch, Miriam Schenk, Michael Volkmar, Nathalia A. Giese
Publikováno v:
Viruses, Vol 13, Iss 6, p 1019 (2021)
Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells determines the parvoviral oncolytic efficacy. The interferon/interfero
Externí odkaz:
https://doaj.org/article/5d5ce1a759fd45638411f8ab7d8bf8e3
Autor:
Shereen Keleg, Alexandr Titov, Anette Heller, Thomas Giese, Christine Tjaden, Sufian S Ahmad, Matthias M Gaida, Andrea S Bauer, Jens Werner, Nathalia A Giese
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100178 (2014)
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrati
Externí odkaz:
https://doaj.org/article/5cee059fbc03459d808978ddc759e89a
Autor:
P Sivaramakrishna Rachakonda, Andrea S Bauer, Huaping Xie, Daniele Campa, Cosmeri Rizzato, Federico Canzian, Stefania Beghelli, William Greenhalf, Eithne Costello, Michaela Schanne, Anette Heller, Aldo Scarpa, John P Neoptolemos, Jens Werner, Markus Büchler, Jörg D Hoheisel, Kari Hemminki, Nathalia Giese, Rajiv Kumar
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60870 (2013)
KRAS mutations are major factors involved in initiation and maintenance of pancreatic tumors. The impact of different mutations on patient survival has not been clearly defined. We screened tumors from 171 pancreatic cancer patients for mutations in
Externí odkaz:
https://doaj.org/article/c15defcb1b3b44cb9aebfc5a3add6314
Autor:
Johannes Fredebohm, Michael Boettcher, Christian Eisen, Matthias M Gaida, Anette Heller, Shereen Keleg, Jörg Tost, Karin M Greulich-Bode, Agnes Hotz-Wagenblatt, Mark Lathrop, Nathalia A Giese, Jörg D Hoheisel
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48503 (2012)
Standard cancer cell lines do not model the intratumoural heterogeneity situation sufficiently. Clonal selection leads to a homogeneous population of cells by genetic drift. Heterogeneity of tumour cells, however, is particularly critical for therape
Externí odkaz:
https://doaj.org/article/9ea8793c424e46499de4989199b7c073
Autor:
Thilo Welsch, Stefanie Zschäbitz, Verena Becker, Thomas Giese, Frank Bergmann, Ulf Hinz, Shereen Keleg, Anette Heller, Bence Sipos, Ursula Klingmüller, Markus W Büchler, Jens Werner, Nathalia A Giese
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23151 (2011)
BACKGROUND: Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). METHODOLOGY
Externí odkaz:
https://doaj.org/article/4ae0036f8eda4914917ab2c185f4fc70
Autor:
Nathalia A. Giese, Barbara Leuchs, Matthias Neulinger-Muñoz, Svetlana P Grekova, Michael Volkmar, Dominik Schaack, Anette Heller, Andrea S. Bauer, Elisa Espinet, Jürg P. F. Nüesch, Gabriel Alexander Salg, Thomas Giese, Miriam Schenk
Publikováno v:
Viruses
Volume 13
Issue 6
Viruses, Vol 13, Iss 1019, p 1019 (2021)
Volume 13
Issue 6
Viruses, Vol 13, Iss 1019, p 1019 (2021)
Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells determines the parvoviral oncolytic efficacy. The interferon/interfero
Publikováno v:
Cellular Oncology. 40:401-409
The ability of tumor cells to invade and metastasize is relevant to the process of cancer progression and, as such, it represents an obstacle to cancer cure. So far, limited information is available on interactions between circulating tumor cells and
Publikováno v:
Gastroenterology. 158:S-1117
Autor:
Matthias Neulinger Munoz, Svetlana P. Grekova, Anette Heller, Miriam Schenk, Thilo Hackert, Oliver Strobel, Nathalia A. Giese
Publikováno v:
Pancreatology. 19:S81